Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469748/
https://www.ncbi.nlm.nih.gov/pubmed/37664865
http://dx.doi.org/10.1155/2023/9853760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469748/
https://www.ncbi.nlm.nih.gov/pubmed/37664865
http://dx.doi.org/10.1155/2023/9853760

Ejemplares similares